Evidence map›Paper›PMID 41725898›Full record

ArticleSynthetic and systems biotechnology2026

Construction and analysis of a cell factory for terpenoid biosynthesis in

Chenfan Sun, Cuifang Ye, Xiaoqian Li, Jiabin Xu, Huiru Yu, Jucan Gao, Chengran Guan, Jintao Cheng

Abstract read
In one paragraph

Article in Synthetic and systems biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Metabolic engineering ofApplied and environmental microbiology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chenfan SunZhejiang Key Laboratory of Public Health Detection and Pathogenesis Research, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Cuifang YeXianghu Laboratory, Hangzhou, 310027, China.
Xiaoqian LiXianghu Laboratory, Hangzhou, 310027, China.
Jiabin XuXianghu Laboratory, Hangzhou, 310027, China.
Huiru YuXianghu Laboratory, Hangzhou, 310027, China.
Jucan GaoKey Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310014, China.
Chengran GuanKey Lab of Dairy Biotechnology and Safety Control, College of Food Science and Engineering, Yangzhou University, Jiangsu, 225127, China.
Jintao ChengXianghu Laboratory, Hangzhou, 310027, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terpenoids are widely distributed in nature and have various applications in health products, pharmaceuticals, and fragrances. Despite the tremendous potential of terpenoids, traditional production methods such as plant extraction and chemical synthesis face challenges in meeting current market demands. With the developments in synthetic biology and metabolic engineering, it has become feasible to construct efficient microbial cell factories for large-scale production for terpenoids. In this work, using the yeast

Indexed as

MetabolomicsMicrobial metabolic engineeringMVA pathwayTerpenoidVersatile chassis

Identifiers

PMID41725898
PMCPMC12923922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.